新冠疫情期间与邮寄粪便免疫化学检测接受情况相关的社会人口学因素：物质使用与年轻人筛查完成率降低有关。 - Suppr | 超能文献

相似文献

1

Sociodemographic Factors Associated with Mailed Fecal Immunochemical Testing Uptake During the COVID-19 Pandemic: Substance Use Linked to Reduced Screening Completion in Younger Adults.新冠疫情期间与邮寄粪便免疫化学检测接受情况相关的社会人口学因素：物质使用与年轻人筛查完成率降低有关。

J Gastrointest Cancer. 2024 Sep;55(3):1453-1455. doi: 10.1007/s12029-024-01057-z. Epub 2024 May 1.

2

Understanding Patient Perspectives to Improve Colorectal Cancer Screening Following the COVID-19 Pandemic: Assessment of a Mailed Fecal Immunochemical Testing Program.了解患者观点以改善新冠疫情后的结直肠癌筛查：邮寄粪便免疫化学检测项目评估

J Gastrointest Cancer. 2024 Sep;55(3):1460-1462. doi: 10.1007/s12029-024-01041-7. Epub 2024 May 20.

3

Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit.邮寄粪便免疫化学试验进行结直肠癌筛查：疾病预防控制中心主办的峰会总结。

CA Cancer J Clin. 2020 Jul;70(4):283-298. doi: 10.3322/caac.21615. Epub 2020 Jun 25.

4

Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial.通过邮寄粪便免疫化学检测试剂盒增加结直肠癌筛查效果的干预措施的调节因素：一项实用随机试验的结果。

Trials. 2020 Jan 15;21(1):91. doi: 10.1186/s13063-019-4027-7.

5

Using physician-linked mailed invitations in an organised colorectal cancer screening programme: effectiveness and factors associated with response.在一项有组织的结直肠癌筛查项目中使用与医生相关的邮寄邀请函：有效性及与回应相关的因素

BMJ Open. 2014 Mar 12;4(3):e004494. doi: 10.1136/bmjopen-2013-004494.

6

Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study.针对医疗补助计划和医疗保险参保人的直接向成员邮寄的结直肠癌筛查外展活动：BeneFIT 研究的实施和效果结果。

Cancer. 2020 Feb 1;126(3):540-548. doi: 10.1002/cncr.32567. Epub 2019 Oct 28.

7

Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy.COVID-19 大流行对粪便免疫化学检测筛查参与度和诊断性结肠镜检查遵从性的影响。

J Gastroenterol Hepatol. 2021 Jun;36(6):1614-1619. doi: 10.1111/jgh.15325. Epub 2020 Dec 2.

8

Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in Washington State.华盛顿州联邦合格健康中心实施的多层结直肠癌筛查推广干预措施的效果和成本。

Cancer. 2018 Nov 1;124(21):4121-4129. doi: 10.1002/cncr.31693. Epub 2018 Oct 25.

9

Implementing Mailed Colorectal Cancer Fecal Screening Tests in Real-World Primary Care Settings: Promising Implementation Practices and Opportunities for Improvement.在真实初级保健环境中实施邮寄结直肠癌粪便筛查检测：有前景的实施实践和改进机会。

Prev Sci. 2024 Apr;25(Suppl 1):124-135. doi: 10.1007/s11121-023-01496-3. Epub 2023 Mar 23.

10

Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.多次粪便免疫化学检测受试者的间期结直肠癌发病率。

Gastroenterology. 2017 Aug;153(2):439-447.e2. doi: 10.1053/j.gastro.2017.05.004. Epub 2017 May 5.

本文引用的文献

1

Lifestyle predictors for inconsistent participation to fecal based colorectal cancer screening.影响基于粪便的结直肠癌筛查参与度不一致的生活方式预测因素。

BMC Cancer. 2022 Feb 15;22(1):172. doi: 10.1186/s12885-022-09287-9.

2

The Impact of the Coronavirus Disease-19 Pandemic on Access to Endoscopy Procedures in the VA Healthcare System.2019冠状病毒病大流行对退伍军人事务部医疗保健系统内镜检查可及性的影响。

Gastroenterology. 2020 Oct;159(4):1216-1220.e1. doi: 10.1053/j.gastro.2020.07.033. Epub 2020 Jul 22.

3

Individual and Geospatial Characteristics Associated With Use and Nonuse of the Fecal Immunochemical Test (FIT) for Colorectal Cancer Screening in an Urban Minority Population.